REV3L and myeloid sarcoma: Recently, Tomas-Roca et al. [8] reported de novo mutations in MS patients affecting the PLXND1 and REV3L genes which cause a defect in the facial branchiomotor neuron migration supporting these genes as causative for a proportion of MS cases.